Cheaper Than a Therapist, Legal-ish, and Completely Unregulated

At nearly every training I teach, someone asks a version of the same question: "Do I really need to be a therapist to do this work?" The room expects one of two answers. The guild answer: yes, obviously, this is clinical work and licensure protects the public. The market answer: no, licensure is gatekeeping, and the medicine belongs to everyone. I refuse to give either one, because both are self-serving stories, and the honest answer is more uncomfortable than either camp wants it to be.

The question stopped being theoretical. The psychedelic coach versus therapist distinction is now a live staffing decision: STAT reported this spring on unlicensed "psychedelic coaches" being added to ketamine treatment as a lower-cost alternative to therapists, with researchers, including a team at Massachusetts General Hospital, now studying whether psychological support changes ketamine outcomes at all. Coaches are cheaper, abundant, and operating in a regulatory vacuum. Licensed clinicians are watching them enter the lane and wondering what to think.

Here's what I think, with my stake disclosed as we go.

Start with why this role exists, because the answer isn't "grifters discovered psychedelics." Therapy is priced beyond what most people seeking ketamine treatment can pay, and the path to becoming a psychedelic-specialized clinician runs through graduate school, licensure, and specialty trainings that routinely cost $7,000 to $15,000. When competent care is priced out of reach and the training pipeline is gatekept by tuition, the market routes around both. That's not a personal failure of anyone who hires a coach or becomes one. It's the market structure doing exactly what market structures do with unmet demand.

So the coaching boom is a verdict on the field's economics. The $10,000 training requirement was sold as a quality signal; the bill for that barrier is now coming due, in the form of a parallel workforce with no training floor at all. You don't get to build a tollbooth and then act shocked that people found the dirt road.

There's an evidence layer underneath the workforce fight, and it cuts in an inconvenient direction for my side. A 2025 study in the Journal of Affective Disorders found that in a real-world, help-seeking sample, adding psychotherapy to ketamine produced no additional benefit over ketamine alone for depression or PTSD outcomes.

That study has real limitations: it wasn't randomized, the sample was self-selected, and the dose and quality of the therapy provided were unmeasured, which matters enormously when the question is whether therapy works. A registered randomized trial will test the comparison directly. But intellectual honesty requires saying it plainly: the claim that therapy is essential to ketamine treatment is currently a clinical conviction with contested evidence, not a settled fact.

Notice who needs which answer. The ketamine industry's margins improve if therapy is unnecessary; the training industry's margins depend on therapy being essential. Both have financial reasons to read the data the way they do, and so do I, as someone who sells clinical training. The coaching question and the "does therapy add anything" question are the same question wearing different clothes, and nobody asking it is neutral.

So strip the guild interest out and ask what's left. In my read, four things, and they're non-negotiable regardless of how the outcome trials land:

• Risk assessment. Recognizing and responding to suicidal ideation, psychosis risk, and acute destabilization is clinical work. The skill isn't administering a checklist; it's knowing what to do when the answers are bad, at a moment when the person in front of you is in a non-ordinary state.
• Contraindication screening. Deciding who shouldn't receive ketamine, or shouldn't receive it now, requires medical and psychological assessment that no weekend certificate confers.
• Trauma work. Non-ordinary states surface traumatic material without asking permission. Working with what surfaces, rather than around it, is the difference between integration and re-injury.
• Power and suggestibility. Ketamine and psychedelics heighten suggestibility, and the practitioner–client power differential intensifies with it. Licensed clinicians have enforceable ethics codes, boards, and consequences. A coach who exploits that differential, sexually, financially, or ideologically, faces a refund request. This one, to me, is the bright line: the more suggestible the client, the more the role demands real accountability structures, and coaching has none.

The guild answer fails because plenty of what surrounds this treatment doesn't require a license, and pretending otherwise is rent-seeking. Psychoeducation about what a dissociative experience feels like. Logistics, scheduling, and accompaniment. Encouragement to follow through on intentions a client set with their prescriber or therapist. Peer support from someone with lived experience, which has its own evidence base in mental health and recovery contexts and which licensure neither confers nor improves. A field that insists every adjacent role be licensed isn't protecting the public; it's protecting a fee schedule.

The problem with the current coaching market isn't that these roles exist. It's that nothing in the market distinguishes a coach doing peer support from a coach doing unsupervised trauma work on a dissociated client, and the client can't tell the difference until something goes wrong.

Practically, for the clinicians this blog is written for: you will increasingly find a coach already in your client's care picture. A few orientations that have served me. Treat the coach as collateral contact, not a colleague bound by your ethics code, and document accordingly. Be precise with your client about what each role can and can't do, especially around crisis response. If a coach is operating inside the four functions above, that's a safety conversation with your client, not a turf complaint. And where your own role bumps against questions of what you may delegate or co-treat, that's a question for your licensing board, not for anyone's blog post.

The field needs a training floor that's accessible enough to be universal, which is the actual answer to the question I get asked at trainings: not "you must be a therapist" or "anyone can do this," but "the dangerous parts are clinical, the rest isn't, and the price of learning the difference shouldn't be $10,000."

This course covers the power dynamics, scope boundaries, and accountability structures this post argues are the bright line, at a price that's consistent with the argument.

A therapist is licensed, with enforceable ethics codes, a board, and consequences; a psychedelic coach is unlicensed and largely unregulated. The meaningful difference is accountability and clinical scope, not job title. Coaches are cheaper and abundant, but nothing in the current market distinguishes one doing peer support from one doing unsupervised trauma work on a dissociated client.

Four things: risk assessment (suicidal ideation, psychosis risk, acute destabilization), contraindication screening, trauma work when non-ordinary states surface it, and managing the heightened suggestibility and power differential these states create. These require clinical training and real accountability structures regardless of how outcome trials land, and coaching currently has none of the latter.

Plenty: psychoeducation about what a dissociative experience feels like, logistics and scheduling, accompaniment, encouragement to follow through on intentions, and peer support from someone with lived experience, which has its own evidence base. Insisting every adjacent role be licensed protects a fee schedule, not the public. The dangerous parts are clinical; much of the rest is not.

It is contested, not settled. A 2025 real-world study found adding psychotherapy to ketamine produced no additional benefit for depression or PTSD, though it was not randomized and the therapy was unmeasured. A registered trial (NCT06559826) will test it directly. Claiming therapy is essential is currently a clinical conviction, not an established fact.